- Raised $23M funding round led by Pitango HealthTech, Jul 2025
- Raised $1.3M funding round, Mar 2023
- Raised $2.6M grant, Jun 2022
About
Restore Medical is dedicated to improve the treatment of congestive heart failure (CHF) by developing innovative and disruptive medical device that will reduce hospitalizations, mortality, and morbidity. The company has developed the first and only transcatheter Pulmonary Artery Banding (PAB) system for the treatment of HFrEF patients.
ContraBand is an innovative and reversible therapy for the treatment of left ventricle (LV) failure. The catheter-delivered implant is designed to leverage the right ventricle (RV) to provide support to the LV, improving LV ejection fraction and restoring optimal ventricular geometry. With no approved treatments currently available for this condition, ContraBand has the potential to transform the way congestive heart failure (CHF) patients are treated.
Ongoing Clinical trial have demonstrated that ContraBand is a highly effective and safe treatment for patients with LV failure. The implantation procedure for ContraBand is simple and time effective.
Funding history · 5 rounds · $29.4M total
Q&A
- What is Restore Medical's primary focus?
- Restore Medical is dedicated to improving the treatment of congestive heart failure (CHF) by developing innovative medical devices. The company has developed the first and only transcatheter Pulmonary Artery Banding (PAB) system for HFrEF patients.
- What is ContraBand and what does it do?
- ContraBand is an innovative and reversible therapy for left ventricle (LV) failure. It is a catheter-delivered implant designed to leverage the right ventricle (RV) to support the LV, aiming to improve LV ejection fraction and restore optimal ventricular geometry.
- When was Restore Medical founded?
- Restore Medical was founded in February 2015.
- How many employees does Restore Medical have?
- Restore Medical has 11-50 employees.
- What is the total amount of funding Restore Medical has raised to date?
- Restore Medical has raised a total of $29,430,000 across multiple funding rounds.
- When did Restore Medical secure its most recent funding round and who were the lead investors?
- In July 2025, Restore Medical secured a $23,000,000 funding round. Pitango HealthTech was a lead investor.
- Which investors have participated in Restore Medical's funding rounds?
- Investors in Restore Medical's funding rounds include Peregrine Ventures.
- What is the current product stage of Restore Medical's technology?
- Restore Medical's product is currently in the clinical trial stage.
- Who are the co-founders of Restore Medical?
- The co-founders of Restore Medical are Elchanan Bruckheimer, who serves as Co-founder & CMO, and Stephen Bellomo, who is Co-founder & VP Clinical Affairs.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | restoremedical.co/ |
|---|---|
| linkedin.com/company/30659944 |
Identifiers & details
| Founded | 2015-2 |
|---|---|
| Employees (exact) | 14 |
Radar intelligence
Patents
| EPO | 37 |
|---|
Web history (Wayback)
| Domain | restoremedical.co |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|